You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Augmentin Duo Forte is indicated for the short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology) *Urinary tract infections (uncomplicated and complicated); *Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis; *Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis; *Skin and skin structure infection Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin Duo Forte. However when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in the product information, therapy may be instituted prior to obtaining the results of bacteriological and susceptibility studies. Once the results are known, therapy should be adjusted should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo Forte should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo Forte.
a white to off-white capsule-shaped film coated tablet, monogrammed with an 'A' and 'C' and a breakline on one side and 'A' and 'C' only on the other side.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Augmentin Duo Forte is indicated for the short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology) *Urinary tract infections (uncomplicated and complicated); *Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis; *Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis; *Skin and skin structure infection Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin Duo Forte. However when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in the product information, therapy may be instituted prior to obtaining the results of bacteriological and susceptibility studies. Once the results are known, therapy should be adjusted should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo Forte should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo Forte.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Augmentin Duo Forte is indicated for the short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to Microbiology) *Urinary tract infections (uncomplicated and complicated); *Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis; *Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis; *Skin and skin structure infection Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin Duo Forte. However when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in the product information, therapy may be instituted prior to obtaining the results of bacteriological and susceptibility studies. Once the results are known, therapy should be adjusted should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo Forte should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo Forte.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
